Navigation Links
Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
Date:1/5/2009

SAN JOSE, Calif., Jan. 5 /PRNewswire/ -- Women undergoing in vitro fertilization (IVF) require progesterone medication to help support early pregnancy, but the intramuscular injections for some forms of this medication can be painful for patients. Formulations of progesterone medication which can be administered by subcutaneous injection or vaginal suppository may offer similar results with better patient tolerance.

With patient well-being a constant focus, Fertility Physicians is participating in an international research study to compare an experimental progesterone, Progesterone-IBSA, which is given by subcutaneous injection, to an FDA approved progesterone, Endometrin(R), which is administered vaginally. The study will assess the efficacy, tolerability and safety of Progesterone-IBSA, the study medication, in female patients undergoing IVF.

"We are so pleased to be one of only 8 clinics across the nation asked to participate. The outcome of this study could mean improved comfort and cost for patients undergoing fertility treatment." said Dr. Purcell.

Patients choosing to participate will benefit by receiving progesterone medication (Endometrin(R) or Progesterone-IBSA) for one IVF cycle, at no charge. This represents approximately a $1,036 value. Additionally, $1,500 will be given to each study participant for their time and commitment. Patients will be responsible for all other charges relating to their IVF cycle and treatment.

Enrollment for this research study is now open and patients interested in participating are invited to call the research department at Fertility Physicians for further information on the study.

Dr. Karen Purcell, MD, PhD, FACOG is directing this study at Fertility Physicians of Northern California, along with Angie Toyama, clinical research coordinator. This research study is sponsored by Institut Biochimique SA (IBSA), an established pharmaceutical company in Switzerland.

About Fertility Physicians of Northern California

Founded in 1984, Fertility Physicians of Northern California (FPNC) offers the full range of medical solutions patients need to start a family, from simple drug therapy to advanced procedures such as in vitro fertilization and pre-implantation genetic diagnosis.

From private offices in San Jose and Palo Alto (CA) they have helped thousands of people become parents. FPNC services include the highest levels of patient care, emotional support and educational programs to assist patients throughout their treatment.

FPNC physicians are board certified specialists in reproductive endocrinology, infertility and reproductive surgery, providing the most advanced training and education in the treatment of infertility, endometriosis, miscarriage and other reproductive disorders. The clinical, nursing and laboratory staff is also composed of highly trained experts.

For more information, please visit: http://www.fpnc.com/team/research


'/>"/>
SOURCE Fertility Physicians of Northern California
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Nationwide Survey Shows Infertility Patients Prefer ENDOMETRIN(R) Compared With Other Progesterone Supplements
2. FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids
3. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
4. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
5. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
6. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
7. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
8. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
9. Physicians Reconsider Implications of Enhance Trial
10. Physicians Will Benefit from Medical Software Advice Website
11. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
Breaking Medicine News(10 mins):